Combining (preclinical) imaging and targeted therapy, is the basis of theranostics. In this webinar, Dr. Florea will highlight several studies performed at RWTH Aachen, where SPECT-CT non-invasive imaging was used to evaluate theranostic compounds.

With new features for both acquisition & analysis Aura Software enables you to capture and analyze your data quickly, easily and accurately. 

Highlighting bioluminescent imaging in Oncology applications with Dr. Michael Henry, Professor of department of Molecular Physiology & Biophysics, University of Iowa Carver College of Medicine.

Spectral Instrument Imaging just announced a new, strategic partnership with InVivo Analytics, which enables quantitative analysis of bioluminescent reporter distributions across different animals, entire cohorts and study time points.

Biological effects of Cs-137 and X-ray irradiators are comparable with regards to reconstitution chimerism in normal and autoimmune settings.

Spectral Instruments Imaging provides unrivaled sensitivity for bioluminescence, fluorescence and X-Ray for in vivo imaging analysis.

By combining study design, study management, and image analytics in all major imaging modalities, BioLaurus has conducted critical preclinical and clinical stage drug development studies.

This is the first of a 4-part series introducing Scintica’s newly formed relationship with IVIM Technology and their IntraVital Microscopy platform (IVM).

Intravital microscopy can visualize various in vivo cellular-level dynamics such as cell trafficking, cell-to-cell or cell-to-microenvironment interactions in a living animal. Intravital imaging of pathophysiological cellular dynamics in natural in vivo microenvironment in various preclinical animal model can provide an unprecedented insight in the dynamic processes of human diseases beyond conventional histological observation of ex vivo sample or in vitro culture sample.